Nouryant
Country: European Union
Language: Portuguese
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
11-10-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Istradefylline
Available from:
Kyowa Kirin Holdings B.V.
ATC code:
N04
INN (International Name):
istradefylline
Therapeutic group:
Anti-Parkinson
Therapeutic area:
Doença de Parkinson
Therapeutic indications:
Istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with Parkinson’s disease (PD) experiencing “OFF” time.
Authorization status:
Recusou
